Patents by Inventor Victoria L. Boyd
Victoria L. Boyd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20180371549Abstract: Compositions, methods, and kits for reducing strand amplification bias using bisulfite treated gDNA are provided. Methods for detecting and for quantitating the amplified bisulfite treated gDNA and inferring the presence, absence, and/or degree of methylation of target cytosine(s) in the gDNA are also provided. Such methods typically employ tailed first primer pairs, which can, but need not comprise nucleotide analogs, and optionally second primer pairs.Type: ApplicationFiled: September 5, 2018Publication date: December 27, 2018Inventor: Victoria L. BOYD
-
Publication number: 20110195405Abstract: Compositions, methods, and kits for reducing strand amplification bias using bisulfite treated gDNA are provided. Methods for detecting and for quantitating the amplified bisulfite treated gDNA and inferring the presence, absence, and/or degree of methylation of target cytosine(s) in the gDNA are also provided. Such methods typically employ tailed first primer pairs, which can, but need not comprise nucleotide analogs, and optionally second primer pairs.Type: ApplicationFiled: December 7, 2010Publication date: August 11, 2011Applicant: LIFE TECHNOLOGIES CORPORATIONInventor: Victoria L. BOYD
-
Publication number: 20100087641Abstract: The invention provides methods and materials for the conversion of cytosine to uracil. A nucleic acid, such a gDNA, is reacted with bisulfate, such as magnesium bisulfite, in the presence of a quaternary amine catalyst. Examples of suitable quaternary amine catalysts include but are not limited to quaternary ammonium compounds, quaternary alkyl ammonium salts, quaternary alkyl ammonium halides, quaternary methyl ammonium bromide, quaternary ammonium chloride, tetraethyl ammonium hydroxide, tetraethylammonium chloride, tetrabutyl ammonium chloride, tetrabutyl ammonium bromide. The invention also contemplates kits of premeasured ingredients for carrying out the methods of the invention either on an individual sample or on a plurality of samples.Type: ApplicationFiled: May 19, 2009Publication date: April 8, 2010Inventors: Victoria L. Boyd, Gerald Zon
-
Publication number: 20100028890Abstract: Compositions, methods, and kits for reducing strand amplification bias using bisulfite treated gDNA are provided. Methods for detecting and for quantitating the amplified bisulfite treated gDNA and inferring the presence, absence, and/or degree of methylation of target cytosine(s) in the gDNA are also provided. Such methods typically employ tailed first primer pairs, which can, but need not comprise nucleotide analogs, and optionally second primer pairs.Type: ApplicationFiled: July 6, 2009Publication date: February 4, 2010Applicant: LIFE TECHNOLOGIES CORPORATIONInventor: Victoria L. BOYD
-
Patent number: 7534873Abstract: The invention provides methods and materials for the conversion of cytosine to uracil. A nucleic acid, such a gDNA, is reacted with bisulfate, such as magnesium bisulfite, in the presence of a quaternary amine catalyst. Examples of suitable quaternary amine catalysts include but are not limited to quaternary ammonium compounds, quaternary alkyl ammonium salts, quaternary alkyl ammonium halides, quaternary methyl ammonium bromide, quaternary ammonium chloride, tetraethylammonium hydroxide, tetraethylammonium chloride, tetrabutylammonium chloride, tetrabutylammonium bromide. The invention also contemplates kits of premeasured ingredients for carrying out the methods of the invention either on an individual sample or on a plurality of samples.Type: GrantFiled: August 26, 2004Date of Patent: May 19, 2009Assignee: Applied Biosystems, LLCInventors: Gerald Zon, Victoria L. Boyd
-
Patent number: 7371526Abstract: The invention provides methods and materials for conversion of cytosine to uracil. In some embodiments, a nucleic acid, such as gDNA, is reacted with at least one bisulfite salt having the formula X+HSO3? or Y+2(HSO331)2; wherein X+ is ammonium ion, a tetraalkyl ammonium ion, or a group 1A ion other than sodium; and Y+2 is a group 2A ion or a group 7B ion; under conditions effective to convert at least one cytosine nucleobase to a uracil nucleobase. In some embodiments, X+ comprises at least one of lithium ion, potassium ion, ammonium ion, tetraalkylammonium ion, magnesium ion, manganese ion and calcium ion. In some embodiments, the reacting is performed optionally in the presence of a polyamine catalyst and/or a quaternary amine catalyst. Also provided are kits that can be used to carry out methods of the invention.Type: GrantFiled: August 26, 2004Date of Patent: May 13, 2008Assignee: Applera CorporationInventors: Gerald Zon, Victoria L. Boyd
-
Patent number: 7368239Abstract: The invention provides methods and materials for conversion of cytosine to uracil. In some embodiments, a nucleic acid, such as gDNA, is reacted with bisulfite and a polyamine catalyst, such as a triamine or tetra-amine. Optionally, the bisulfite comprises magnesium bisulfite. In other embodiments, a nucleic acid is reacted with magnesium bisulfite, optionally in the presence of a polyamine catalyst and/or a quaternary amine catalyst. Also provided are kits that can be used to carry out methods of the invention.Type: GrantFiled: August 26, 2004Date of Patent: May 6, 2008Assignee: Applera CorporationInventors: Gerald Zon, Victoria L. Boyd
-
Patent number: 7262013Abstract: The invention provides methods for purifying bisulfite-treated nucleic acid samples.Type: GrantFiled: August 26, 2004Date of Patent: August 28, 2007Assignee: Applera CorporationInventors: Victoria L. Boyd, Gerald Zon
-
Patent number: 6825010Abstract: The invention relates generally to the field of nucleic acid sequence analysis. In certain embodiments, the analysis is genotyping. In certain embodiments, the analysis involves detecting single nucleotide polymorphisms (SNPs). The invention also relates to methods, kits, and computer software for nucleic acid analysis.Type: GrantFiled: April 16, 2002Date of Patent: November 30, 2004Assignee: Applera CorporationInventors: Eugene Spier, Victoria L. Boyd
-
Publication number: 20030082572Abstract: The invention relates generally to the field of nucleic acid sequence analysis. In certain embodiments, the analysis is genotyping. In certain embodiments, the analysis involves detecting single nucleotide polymorphisms (SNPs). The invention also relates to methods, kits, and computer software for nucleic acid analysis.Type: ApplicationFiled: April 16, 2002Publication date: May 1, 2003Inventors: Eugene Spier, Victoria L. Boyd
-
Patent number: 5665603Abstract: A method of forming a thiohydantoin from an N-protected amino acid is described. The method employs a phosphate compound selected from the group consisting of(R.sub.1 O)(R.sub.2 O)P(.dbd.O)X and(R.sub.1 O)(R.sub.2 O)P(.dbd.O)--O--P(.dbd.O)(OR.sub.3)(OR.sub.4)to form acylphosphate moieties from the carboxyl groups of internal aspartic acid and glutamic acid residues and an acylphosphate moiety at a C-terminal carboxyl. The later acylphosphate, unlike the internal acylphosphates, spontaneously cyclizes to an oxazolone, which is less reactive with nucleophilic reagents. R.sub.1 and R.sub.2 are each alkyl, aryl, or alkaryl groups which are the same or different and which may be covalently linked to each other; R.sub.3 and R.sub.4 are each alkyl, aryl, or alkaryl groups which are the same or different and which may be covalently linked to each other; and X is a leaving group, such as chlorine or bromine, which is substantially unreactive towards thiohydantoins.Type: GrantFiled: July 8, 1994Date of Patent: September 9, 1997Assignee: The Perkin-Elmer CorporationInventors: Victoria L. Boyd, MeriLisa Bozzini, Robert J. DeFranco
-
Patent number: 5602207Abstract: A solid support and method for immobilization and sequence analysis of polypeptides. In one aspect, the invention is directed to a method for immobilizing a polypeptide on a solid support. In the method, a solid support having surface-attached carboxylic acid groups is reacted with an isoxazolium salt to form an activated support. After the activated support has been washed to remove residual isoxazolium salt and base, the support is dried. The dried support is then contacted with a polypeptide under conditions effective to bind the polypeptide covalently to the support. The immobilized polypeptide can be conveniently sequenced by N- and C-terminal sequencing methods.Type: GrantFiled: September 29, 1993Date of Patent: February 11, 1997Assignee: The Perkin-Elmer CorporationInventors: Victoria L. Boyd, Pau-Miau Yuan
-
Patent number: 5468843Abstract: A method is provided for C-terminal sequencing of a protein or peptide. An important feature of the method is the formation of an oxazolone moiety at the C-terminus of a protein or peptide by treatment with acetic anhydride under basic conditions followed by conversion of the oxazolone to a thiohydantoin moiety by treatment with thiocyanate under acidic conditions. Yields of thiohydantoin are further enhanced by delivering thiocyanate as the conjugate acid of a sterically hindered alkylammnonium cation.Type: GrantFiled: September 8, 1994Date of Patent: November 21, 1995Assignee: Perkin-ElmerInventors: Victoria L. Boyd, MeriLisa Bozzini, G. Marc Loudon
-
Patent number: 5304497Abstract: A method of forming a thiohydantoin from an N-protected amino acid. The method employs a uronium or phosphonium compound to activate the terminal carboxyl group of the amino acid and a thiocyanate reagent to cyclize the activated amino acid to the thio-hydantoin. The thiohydantoin can be cleaved from its N-protecting group, for use in C-terminal peptide sequencing. Particularly preferred uronium compounds include salts of 2-chlorouronium. Preferred thiocyanate reagents include trimethylsilyl isothiocyanate and crown ether adducts of metallothiocyanates, such as the 18-crown-6 adduct of KSCN.Type: GrantFiled: July 15, 1992Date of Patent: April 19, 1994Assignee: Applied Biosystems, Inc.Inventors: Victoria L. Boyd, MeriLisa Bozzini, Piotr J. Guga, Gerald Zon
-
Patent number: 5185266Abstract: Disclosed is a method for enhancing the cleavage of an acyl thiohydantoin bond, for example, for use in C-terminal peptide sequencing. An acyl thiohydantoin is alkylated to form an adduct on the thiohydantoin, and the adduct-containing thiohydantoin is cleaved at its acyl bond by reaction with a cleaving agent under substantially anhydrous, acidic conditions. In C-terminal amino acid sequencing, the cleaved product is analyzed to identify the C-terminal amino acid.Type: GrantFiled: October 15, 1991Date of Patent: February 9, 1993Assignee: Applied Biosystems, Inc.Inventors: Victoria L. Boyd, Gerald Zon
-
Patent number: 5051368Abstract: A method of forming an amino acid thiohydantoin from an N-protected amino acid or the C-terminal amino acid of an N-protected peptide. The amino acid is activated by reaction with a ketenimine, and the activated ester is converted to the thiohydantoin by reaction with silyl or pyridine isothiocyanate. The ketenimine is generated by treating an N-substituted isoxazolium compound, such as Woodwards Reagent K with a base, preferably in the presence of the amino acid. Also disclosed is a solid phase support having a derivatized N-substituted isoxazolium or ketenimine group for use in the method.Type: GrantFiled: June 29, 1990Date of Patent: September 24, 1991Assignee: Applied Biosystems, Inc.Inventors: Victoria L. Boyd, David H. Hawke, Timothy G. Geiser
-
Patent number: 5049507Abstract: A method of C-terminal peptide sequencing. The peptide is reacted with a mixed anhydride of isothiocyanic acid and a carboxylic, carbonic, or sulfonic acid, under basic conditions, to produce a C-terminal peptidyl thiohydantoin. The C-terminal amino acid can be identified by cleaving the thiohydantoin from the peptide and identifying the free amino acid thiohydantoin.Type: GrantFiled: December 21, 1989Date of Patent: September 17, 1991Assignee: Applied Biosystems, Inc.Inventors: David H. Hawke, Victoria L. Boyd
-
Patent number: 5041388Abstract: A method of C-terminal peptide sequencing. The peptide is reacted with an activated support derivatized with a mixed anhydride of isothiocyanic acid and carboxylic or carbonic acid, under basic conditions. The peptidyl thiohydantoin which forms is separated from the solid support and further reacted with a cleaving agent carried on a second solid support, to release a free C-terminal amino acyl thiohydantoin from the peptide. The free thiohydantoin is analyzed to determine the C-terminal peptide residue. The residual peptide can be recycled through the supports for successive C-terminal residue determinations.Type: GrantFiled: June 29, 1990Date of Patent: August 20, 1991Assignee: Applied Biosystems, Inc.Inventors: Victoria L. Boyd, David H. Hawke